Pharming Group to report Q2 and H1 2026 results on July 30
Pharming Group N.V. will release its preliminary financial results for Q2 and H1 2026 on July 30, 2026, accompanied by a business update. A conference call and webcast are scheduled for the same day at 13:30 CEST. Registration is required for participation.
*this image is generated using AI for illustrative purposes only.
Pharming Group N.V. will report its preliminary financial results for the second quarter and first half of 2026 on July 30, 2026. The company will also provide a business update alongside the results. Management is scheduled to host a conference call and webcast for analysts and investors on the same day at 13:30 CEST (07:30 am EDT).
Participants must register in advance to access the conference call or watch the live webcast. Once registered, dial-in information and a unique PIN will be provided. The company has specified that questions will only be taken from dial-in attendees.
The webcast will be available on the Pharming website under the Investors/Financial Documents & Reports section. A replay of the event will be accessible shortly after the conclusion of the live broadcast.
Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative medicines for rare, debilitating, and life-threatening diseases. The company is headquartered in Leiden, the Netherlands, with operations in the U.S. and Europe.
Event Details
| Event | Date | Time | Access |
|---|---|---|---|
| Results Release | July 30, 2026 | - | - |
| Conference Call | July 30, 2026 | 13:30 CEST / 07:30 am EDT | Registration required |
| Webcast | July 30, 2026 | 13:30 CEST / 07:30 am EDT | Pharming website |
What key performance indicators will investors focus on during the Q2 2026 earnings release?
How might the business update impact Pharming's stock performance in the short term?
Could the conference call reveal any strategic shifts or new partnerships for the company?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
